Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Shares rally, retail surge drives silver to 8-year high

Mon, 01st Feb 2021 10:08

* Global stocks up 0.5%; S&P 500 futures up 1%

* Retail crowd turns gaze on silver, jumps to 8-year high

* Oil up 1%; Dollar index, Bund, T-bill yields steady

* Excess Money? https://tmsnrt.rs/2YpThUB

By Simon Jessop

LONDON, Feb 1 (Reuters) - Global shares bounced and silver
markets surged on Monday as retail investors expanded their
social-media fuelled battle against Wall Street to drive the
precious metal to an eight-year high.

Stock markets were roiled last week after a spike in retail
demand to buy the stocks most bet against by hedge funds drove
huge gains in companies such as GameStop Corp and
prompted fresh concern that COVID-19 monetary and fiscal support
measures were fuelling a market bubble.

With chatrooms abuzz with talk that silver was the new
target, silver-exposed stocks, funds and coins jumped, helping
push spot silver up more than 11%, with London-listed
miners up strongly, including Fresnillo, up 18%.

After falling 3.6% last week - its biggest weekly fall in
three months - the MSCI All-Country World Index
was up 0.5% in early deals, tracking overnight gains in Asia.

MSCI's broadest index of Asia-Pacific shares outside Japan
climbed 1.9% while Japan's Nikkei added
1.5% and Chinese blue chips rose 1.2% after the
country's central bank injected more cash into money markets.

Futures for the S&P 500 and NASDAQ, meanwhile,
both pointed to a stronger open on Wall Street, up around 1%.

While the retail battle versus Wall Street, coordinated over
online forums such as Reddit, created some systemic risks, the
bigger danger was in the tech sector, where some stocks had "eye
watering valuations", Deutsche Bank analyst Jim Reid said.

"Retail has in many parts driven such valuations in the last
10 months. If this pops the wider market will have bigger issues
than last week."

Gold followed silver higher, up 1% to $1,864 an ounce
, while oil also tracked the gains in other commodities,
with both Brent crude and its U.S. peer up around
1%.

While the stock market tussle continued to grab the
headlines, analysts cautioned the bigger concern was economic
momentum in the United States and Europe as coronavirus
lockdowns bite.

Indeed, two surveys from China showed factory activity
slowed in January as restrictions took a toll in some regions.
In the euro zone, manufacturing growth remained resilient at the
start of the year but the pace waned from December. Data from
Britain will be in focus later in the European session.

While the coronavirus vaccine rollout globally remains slow,
with concern about whether they will work on new COVID strains,
Europe was also bolstered by news that it would receive a
further 9 million doses from AstraZeneca in the first quarter.

"It is these considerations, not what is happening to a
video game retailer day to day, that has weighed on risk
assets," said John Briggs, global head of strategy at NatWest
Markets. "So much of the market's valuations, risk in
particular, is premised on the fact we can see a light at the
end of the COVID tunnel."

Higher yields combined with the more cautious market mood
have seen the safe-haven dollar steady above its recent lows.
The dollar index stood at 90.722, having bounced from a
trough of 89.206 hit early in January.

The euro, meanwhile, fell 0.3% to $1.2100, well off
its recent peak at $1.2349, while the pound was the biggest
gainer in the G10 group of currencies, up 0.3% on the day at
$1.3732..

With riskier markets bouncing, Italian government bond
yields fell 2-3 basis points across the curve.

German Bund yields, meanwhile, the benchmark for the euro
zone, remained anchored around -0.51% on Monday, tracking U.S.
Treasury yields that also remained unchanged..

(Additional reporting by Abhinav Ramnarayan and Ritvik
Carvalho; Editing by Toby Chopra, William Maclean)

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslodex, for the treatment of a form of breast cancer.

Read more
18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

Read more
18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with inflation data and central bank decisions the key plot points as the week progresses.

Read more
18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with paclitaxel did not achieve its primary endpoints.

Read more
17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "important new option" for patients.

Read more
17 Jun 2024 07:48

LONDON BRIEFING: Astra gets US drug approval; Ascential trades in line

(Alliance News) - London's FTSE 100 is called to open solidly higher on Monday, recovering some poise after a tricky week, with eyes turning to the Bank of England.

Read more
17 Jun 2024 07:23

IN BRIEF: AstraZeneca gets positive cancer test results for Calquence

AstraZeneca PLC - Cambridge, England-based pharmaceutical maker - Reports promising test results for one of its cancer therapies. The Echo phase III trial shows that Calquence, when used in combination with bendamustine and rituximab, demonstrates a clinically meaningful improvement in progression-free survival in patients with untreated mantle cell lymphoma. Compared to standard-of-care chemoimmunotherapy, the combination with Calquence, whose generic name is acalabrutinib, shows a 27% reduced risk of disease progression or death. Mantle cell lymphoma is rare and typically aggressive form of non-Hodgkin lymphoma, Astra explains.

Read more
17 Jun 2024 07:15

AstraZeneca's Imfinzi gets US approval for endometrial cancer patients

(Sharecast News) - AstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.

Read more
12 Jun 2024 20:56

AstraZeneca's Farxiga approved to treat paediatric type-2 diabetes

(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.

Read more
10 Jun 2024 09:10

LONDON BROKER RATINGS: JPMorgan cuts Aviva but lifts M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more
10 Jun 2024 08:30

TOP NEWS: Astra's Tagrisso gets US priority review for lung cancer

(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of non-small cell lung cancer.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 06:25

London pre-open: Stocks set for lower start after EU elections

(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
5 Jun 2024 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.